Gnetin C Intercepts MTA1-Associated Neoplastic Progression in Prostate Cancer.

In general, prostate tissues from mice in the same treatment group demonstrated an expected trend compared to control mice, however, with noticeable heterogeneity, particularly with respect to p-Akt/Akt in mice in the Gnetin 35 -Diet group ( Figure 4 A, right ) ( Supplementary Figure S1 ).

also in 319 other papers